Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

التفاصيل البيبلوغرافية
العنوان:	Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
المؤلفون:	Maertens, Johan A, Raad, Issam I, Marr, Kieren A, Patterson, Thomas F, Kontoyiannis, Dimitrios P, Cornely, Oliver A, Bow, Eric J, Rahav, Galia, Neofytos, Dionysios, Aoun, Mickael, Baddley, John W, Giladi, Michael, Heinz, Werner J, Herbrecht, Raoul, Hope, William, Karthaus, Meinolf, Lee, Dong-Gun, Lortholary, Olivier, Morrison, Vicki A, Oren, Ilana, Selleslag, Dominik, Shoham, Shmuel, Thompson, George R, III, Lee, Misun, Maher, Rochelle M, Schmitt-Hoffmann, Anne-Hortense, Zeiher, Bernhardt, Ullmann, Andrew J
المصدر:	In The Lancet 20-26 February 2016 387(10020):760-769
قاعدة البيانات:	ScienceDirect

كن أول من يترك تعليقا!